BHMP
AVEO

Bardin Hill Management Partners’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bardin Hill Management Partners’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-638,360
Closed -$9.54M – 106
2022
Q4 		$9.54M Buy
+638,360
New +$8.84M 2.08% 19

Bardin Hill Management Partners's AVEO Position: Q1 2023 in Review

Bardin Hill Management Partners sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 638,360 shares — an estimated $9.54M sold.

Bardin Hill Management Partners first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $9.54M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Bardin Hill Management Partners reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Bardin Hill Management Partners sold 638,360 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $9.54M.
  • Bardin Hill Management Partners first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Bardin Hill Management Partners's AVEO Pharmaceuticals, Inc. position peaked at $9.54M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Bardin Hill Management Partners's 13F filing for Q1 2023, filed 12 May 2023.